Delivery Order SPE2DB22D1017-SPE2DB25FF1ZP

Award Date 12/26/24
Potential Completion Date 12/27/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF1ZP
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,211.44, is a Firm Fixed Price Delivery Order for the supply of 4566796591 - Jardiance 25 mg Tablets. The contract has an ultimate completion date of December 27, 2024. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp, as the prime contractor, will be responsible for delivering the pharmaceutical product to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions served by the DLA. The contract is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to the U.S. government.

Generated 3/27/25, 9:45 AM